• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FLI-1可将尤因肉瘤与小细胞骨肉瘤及间叶性软骨肉瘤区分开来。

FLI-1 distinguishes Ewing sarcoma from small cell osteosarcoma and mesenchymal chondrosarcoma.

作者信息

Lee Anna F, Hayes Malcolm M, Lebrun David, Espinosa Inigo, Nielsen G Petur, Rosenberg Andrew E, Lee Cheng-Han

机构信息

Department of Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada.

出版信息

Appl Immunohistochem Mol Morphol. 2011 May;19(3):233-8. doi: 10.1097/PAI.0b013e3181fd6697.

DOI:10.1097/PAI.0b013e3181fd6697
PMID:21084965
Abstract

Small cell osteosarcoma and mesenchymal chondrosarcoma are 2 primary bone tumors with a small round blue cell component, which can mimic the appearance of Ewing sarcoma. Distinguishing these tumors from each other on biopsy material is important clinically, as optimal therapy differs according to the tumor type. However, separating these entities on morphology alone can be challenging. FLI-1 has been described to be a useful marker for Ewing sarcoma, particularly when hematolymphoid markers are negative. In small cell osteosarcoma and mesenchymal chondrosarcoma, the FLI-1 staining pattern has not been adequately characterized. Using a monoclonal FLI-1 antibody, nuclear immunoreactivity in tumor cells was evaluated in 10 small cell osteosarcomas, 10 mesenchymal chondrosarcomas, and 8 Ewing sarcomas, together with a number of other small, round, blue cell tumors. None of the small cell osteosarcomas or mesenchymal chondrosarcomas exhibited FLI-1 staining in the tumor cells, in contrast to the positive nuclear FLI-1 staining in the stromal endothelial cells. In comparison, 6 of the 8 Ewing sarcomas showed moderate-to-strong nuclear FLI-1 staining of the tumor cells in addition to strong staining of the stromal endothelial cell nuclei. With the exception of lymphoblastic lymphomas, FLI-1 positivity was not seen in the other small round blue cell tumors examined. These findings show that, in contrast to Ewing sarcoma, small cell osteosarcoma and mesenchymal chondrosarcoma lack FLI-1 immunoreactivity. FLI-1 is therefore useful in the differential diagnosis of small round blue cell tumors of the bone.

摘要

小细胞骨肉瘤和间叶性软骨肉瘤是两种具有小圆形蓝细胞成分的原发性骨肿瘤,它们可能会模仿尤因肉瘤的外观。在活检材料上区分这些肿瘤在临床上很重要,因为最佳治疗方法因肿瘤类型而异。然而,仅靠形态学来区分这些实体可能具有挑战性。FLI-1已被描述为尤因肉瘤的一种有用标志物,特别是当血液淋巴标志物为阴性时。在小细胞骨肉瘤和间叶性软骨肉瘤中,FLI-1的染色模式尚未得到充分描述。使用单克隆FLI-1抗体,对10例小细胞骨肉瘤、10例间叶性软骨肉瘤、8例尤因肉瘤以及一些其他小圆形蓝细胞肿瘤的肿瘤细胞中的核免疫反应性进行了评估。与基质内皮细胞核中FLI-1阳性染色形成对比的是,小细胞骨肉瘤或间叶性软骨肉瘤的肿瘤细胞均未表现出FLI-1染色。相比之下,8例尤因肉瘤中有6例除了基质内皮细胞核有强染色外,肿瘤细胞还显示出中度至强的核FLI-1染色。在所检查的其他小圆形蓝细胞肿瘤中,除了淋巴母细胞淋巴瘤外,均未发现FLI-1阳性。这些发现表明,与尤因肉瘤不同,小细胞骨肉瘤和间叶性软骨肉瘤缺乏FLI-1免疫反应性。因此,FLI-1在骨小圆形蓝细胞肿瘤的鉴别诊断中很有用。

相似文献

1
FLI-1 distinguishes Ewing sarcoma from small cell osteosarcoma and mesenchymal chondrosarcoma.FLI-1可将尤因肉瘤与小细胞骨肉瘤及间叶性软骨肉瘤区分开来。
Appl Immunohistochem Mol Morphol. 2011 May;19(3):233-8. doi: 10.1097/PAI.0b013e3181fd6697.
2
Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic considerations.骨小细胞骨肉瘤:一项伴有鉴别诊断考量的免疫组织化学研究
Hum Pathol. 1993 Nov;24(11):1211-25. doi: 10.1016/0046-8177(93)90218-6.
3
NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study.NKX3.1:间叶性软骨肉瘤的一种有用标志物——一项免疫组织化学研究
Ann Diagn Pathol. 2021 Feb;50:151660. doi: 10.1016/j.anndiagpath.2020.151660. Epub 2020 Nov 5.
4
The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.SATB2免疫组化表达在鉴别骨肉瘤与其恶性骨肿瘤模仿者(如尤因肉瘤和软骨肉瘤)中的作用。
Pathol Res Pract. 2016 Sep;212(9):811-6. doi: 10.1016/j.prp.2016.06.012. Epub 2016 Jun 26.
5
Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor.FLI-1蛋白表达的免疫组织化学检测:对132例圆形细胞肿瘤的研究,重点关注尤因肉瘤/原始神经外胚层肿瘤的CD99阳性模拟物。
Am J Surg Pathol. 2000 Dec;24(12):1657-62. doi: 10.1097/00000478-200012000-00010.
6
Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors.Sox9是软骨形成的主要调节因子,可将间叶性软骨肉瘤与其他小圆形蓝色细胞肿瘤区分开来。
Hum Pathol. 2003 Mar;34(3):263-9. doi: 10.1053/hupa.2003.41.
7
Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas and histologic mimics.评估 ETV4 和 WT1 在 CIC 重排肉瘤及组织学类似物中的表达。
Mod Pathol. 2016 Nov;29(11):1324-1334. doi: 10.1038/modpathol.2016.140. Epub 2016 Jul 22.
8
NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma.NKX2.2 是尤文肉瘤的一种有用的免疫组织化学标志物。
Am J Surg Pathol. 2012 Jul;36(7):993-9. doi: 10.1097/PAS.0b013e31824ee43c.
9
Galectin-1 (GAL-1) expression is a useful tool to differentiate between small cell osteosarcoma and Ewing sarcoma.半乳糖凝集素-1(GAL-1)表达是区分小细胞骨肉瘤和尤因肉瘤的有用工具。
Virchows Arch. 2013 Jun;462(6):665-71. doi: 10.1007/s00428-013-1423-3. Epub 2013 May 17.
10
Round cell sarcoma with CIC-DUX4 gene fusion: Discussion of the distinctive cytomorphologic, immunohistochemical, and molecular features in the differential diagnosis of round cell tumors.伴有CIC-DUX4基因融合的圆形细胞肉瘤:圆形细胞肿瘤鉴别诊断中独特细胞形态学、免疫组化及分子特征的探讨
Cancer Cytopathol. 2016 May;124(5):350-61. doi: 10.1002/cncy.21685. Epub 2016 Jan 22.

引用本文的文献

1
Mesenchymal Chondrosarcoma of the Mandible, a Big Dilemma: Report of a Rare Case in Mesenchymal Chondrosarcoma of the Mandible-Report of a Case With Discussion of Diagnostic and Therapeutic Dilemmas.下颌骨间叶性软骨肉瘤:一大难题——1例罕见的下颌骨间叶性软骨肉瘤病例报告及诊断与治疗难题讨论
Case Rep Dent. 2024 Oct 28;2024:8884697. doi: 10.1155/2024/8884697. eCollection 2024.
2
Mesenchymal Chondrosarcoma from Diagnosis to Clinical Trials.从诊断到临床试验的间充质软骨肉瘤
Cancers (Basel). 2023 Sep 15;15(18):4581. doi: 10.3390/cancers15184581.
3
Extraskeletal mesenchymal chondrosarcoma arising from soft tissues: A rare case report.
软组织来源的骨外间叶性软骨肉瘤:罕见病例报告。
Cancer Rep (Hoboken). 2023 Oct;6(10):e1883. doi: 10.1002/cnr2.1883. Epub 2023 Aug 9.
4
Molecular In-Depth Characterization of Chondrosarcoma for Current and Future Targeted Therapies.软骨肉瘤的分子深度表征用于当前及未来的靶向治疗
Cancers (Basel). 2023 Apr 29;15(9):2556. doi: 10.3390/cancers15092556.
5
Ewing's Sarcoma of the Talus in an Adolescent Female: An Unusual Case Presentation With Review of Literature.一名青春期女性距骨尤因肉瘤:罕见病例报告并文献复习
Cureus. 2022 Oct 31;14(10):e30946. doi: 10.7759/cureus.30946. eCollection 2022 Oct.
6
Primary Chondrosarcoma in L-shaped Crossed Fused Renal Ectopia Coexisting with Papillary Urothelial Carcinoma in Urinary Bladder - An Enigmatic Entity with Poor Prognosis.L形交叉融合性肾异位并存膀胱乳头状尿路上皮癌中的原发性软骨肉瘤——一种预后不良的罕见实体
J Kidney Cancer VHL. 2022 Jan 1;9(1):9-14. doi: 10.15586/jkcvhl.v9i1.162. eCollection 2022.
7
Chondrosarcoma-from Molecular Pathology to Novel Therapies.软骨肉瘤——从分子病理学到新型疗法
Cancers (Basel). 2021 May 14;13(10):2390. doi: 10.3390/cancers13102390.
8
Mesenchymal chondrosarcoma: imaging features and clinical findings.间叶性软骨肉瘤:影像学表现与临床特征。
Skeletal Radiol. 2021 Feb;50(2):333-341. doi: 10.1007/s00256-020-03558-x. Epub 2020 Jul 30.
9
Chondrosarcoma in a paediatric population: a study of 247 cases.儿童人群中的软骨肉瘤:一项247例病例的研究。
J Child Orthop. 2019 Feb 1;13(1):89-99. doi: 10.1302/1863-2548.13.180109.
10
Biomarkers of Osteosarcoma, Chondrosarcoma, and Ewing Sarcoma.骨肉瘤、软骨肉瘤和尤因肉瘤的生物标志物。
Front Pharmacol. 2017 Apr 7;8:150. doi: 10.3389/fphar.2017.00150. eCollection 2017.